Published in ILAR J on January 01, 2008
Quantitative detection of Merkel cell virus in human tissues and possible mode of transmission. Int J Cancer (2010) 1.53
A syndrome of severe hypoglycemia and acidosis in young immunosuppressed diabetic monkeys and pigs-association with sepsis. Transplantation (2012) 0.78
Detection and experimental transmission of a novel Babesia isolate in captive olive baboons (Papio cynocephalus anubis). J Am Assoc Lab Anim Sci (2011) 0.78
Self-Injurious Behavior Secondary to Cytomegalovirus-Induced Neuropathy in an SIV-Infected Rhesus Macaque (Macaca mulatta). Comp Med (2015) 0.78
Cynomolgus monkeys are successfully and persistently infected with hepatitis E virus genotype 3 (HEV-3) after long-term immunosuppressive therapy. PLoS One (2017) 0.75
Post-transplant lymphoproliferative disorder associated with immunosuppressive therapy for renal transplantation in rhesus macaques (Macaca mulatta). Exp Toxicol Pathol (2013) 0.75
Nasal, oral and rectal microbiota of Black lion tamarins (Leontopithecus chrysopygus). Braz J Microbiol (2015) 0.75
The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med (1992) 6.05
Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant (2005) 2.76
Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med (2000) 2.63
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant (2004) 2.23
Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin Diagn Lab Immunol (2003) 1.95
Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol (1999) 1.83
The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation (1988) 1.72
Occurrence of cytomegalovirus hepatitis in liver transplant patients. J Med Virol (1988) 1.50
Temple monkeys and health implications of commensalism, Kathmandu, Nepal. Emerg Infect Dis (2006) 1.46
Anti-CD40 therapy extends renal allograft survival in rhesus macaques. Transplantation (2002) 1.40
Fungal infections in solid organ transplantation. Med Mycol (2007) 1.39
Seroepidemiologic studies of cytomegalovirus infection in a breeding population of rhesus macaques. Lab Anim Sci (1994) 1.39
Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients. J Clin Microbiol (1994) 1.36
BK virus nephropathy--polyomavirus adding insult to injury. N Engl J Med (2002) 1.36
Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients. Transplantation (2005) 1.33
Induction of chimerism in rhesus macaques through stem cell transplant and costimulation blockade-based immunosuppression. Am J Transplant (2007) 1.30
Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor. Transplantation (1994) 1.27
High resolution radiographic and fine immunologic definition of TB disease progression in the rhesus macaque. Microbes Infect (2006) 1.26
Infection of human B lymphocytes with lymphocryptoviruses related to Epstein-Barr virus. J Virol (1998) 1.23
Effects of antithymocyte globulin on cytomegalovirus infection in renal transplant recipients. Transplantation (1981) 1.18
Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-human CD154 mAb-based regimen. Am J Transplant (2004) 1.17
Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation. Transplantation (1997) 1.17
Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation (1992) 1.16
Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation. Clin Infect Dis (1999) 1.12
Why hasn't eliminating acute rejection improved graft survival? Annu Rev Med (2007) 1.10
Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus. Transplantation (1997) 1.09
Cynomolgus polyoma virus infection: a new member of the polyoma virus family causes interstitial nephritis, ureteritis, and enteritis in immunosuppressed cynomolgus monkeys. Am J Pathol (1999) 1.08
Immunosuppression by the JAK3 inhibitor CP-690,550 delays rejection and significantly prolongs kidney allograft survival in nonhuman primates. Transplantation (2005) 1.04
Activation of cytomegalovirus in pig-to-primate organ xenotransplantation. J Virol (2002) 1.03
A monkey model for Epstein Barr virus-associated lymphomagenesis in human acquired immunodeficiency syndrome. J Exp Med (1992) 1.03
Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention. Am J Transplant (2004) 1.03
Urinary tract infection in the immunocompromised host. Lessons from kidney transplantation and the AIDS epidemic. Infect Dis Clin North Am (1997) 1.01
Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant (2002) 0.95
Simian parvovirus infection in cynomolgus monkey heart transplant recipients causes death related to severe anemia. Transplantation (2006) 0.95
Nonhuman primate models of intrauterine cytomegalovirus infection. ILAR J (2006) 0.95
A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients. Rev Infect Dis (1982) 0.94
Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole. Transplantation (2003) 0.93
Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy. Transplantation (2003) 0.91
Dosing of intravenous ganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplant recipients. Transplantation (2000) 0.91
Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group. Am J Transplant (2007) 0.90
Shigellosis in rhesus monkeys in quarantine. Lab Anim (1973) 0.90
Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. Transplantation (1995) 0.90
Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir. J Infect Dis (2003) 0.89
Disseminated blastomycosis in a rhesus monkey (Macaca mulatta). Vet Pathol (1999) 0.88
Overview: pathogenesis of fungal infections in the organ transplant recipient. Transpl Infect Dis (2002) 0.88
Epidemiology and management of infections after lung transplantation. Clin Infect Dis (2001) 0.88
Epstein-Barr virus infections in children after transplantation of the small intestine. Am J Surg Pathol (1998) 0.87
Posttransplant lymphoproliferative disorder associated with an Epstein-Barr-related virus in cynomolgus monkeys. Transplantation (2002) 0.87
Isolation of SV40 from the environment of a colony of cynomolgus monkeys naturally infected with the virus. Virology (2004) 0.87
The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation. Nephrol Dial Transplant (2000) 0.86
Mycotic infections of the alimentary tract of nonhuman primates: a review. Vet Pathol Suppl (1982) 0.86
Coccidioidomycosis in a rhesus monkey. J Am Vet Med Assoc (1975) 0.85
Fluconazole therapy for coccidioidomycosis in Japanese macaques. Rev Infect Dis (1990) 0.84
Susceptibility of chacma baboons (Papio ursinus orientalis) to infection by hepatitis B virus. Transplantation (2000) 0.84
Introduction to the Immunocompromised Host Society consensus conference on epidemiology, prevention, diagnosis, and management of infections in solid-organ transplant patients. Clin Infect Dis (2001) 0.84
Management of cytomegalovirus infection by weekly surveillance after renal transplant: analysis of cost, rejection and renal function. Nephrol Dial Transplant (2003) 0.83
Prevalence of shigellosis and other enteric pathogens in a zoologic collection of primates. J Am Vet Med Assoc (1993) 0.83
Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients. J Pediatr (1997) 0.82
Monitoring and diagnosis of cytomegalovirus infection in renal transplantation. J Am Soc Nephrol (1997) 0.80
Opportunistic fungal and bacterial infection in the renal transplant recipient. J Am Soc Nephrol (1992) 0.80
Shigella infection in macaque colonies: case report of an eradication and control program. Lab Anim Sci (1998) 0.79
Molecular and clinical perspectives of polyomaviruses: emerging evidence of importance in non-kidney transplant populations. Liver Transpl (2006) 0.79
Treatment with anti-MHC-class-II antibody postpones kidney allograft rejection in primates but increases the risk of CMV activation. Am J Transplant (2004) 0.79
The prevention of infection post-transplant: the role of prophylaxis, preemptive and empiric therapy. Transpl Int (2006) 0.78
Lymphoproliferative disorders developing after transplantation and their relation to simian T-cell leukemia virus infection. Transpl Int (1992) 0.78
Baboons undergoing orthotopic concordant cardiac xenotransplantation surviving more than 300 days: effect of immunosuppressive regimen. J Thorac Cardiovasc Surg (2003) 0.77
Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients. Transplantation (1999) 0.77
The role of new diagnostic tests in transplant infectious disease. Transpl Infect Dis (2002) 0.77
Cryptococcosis in a renal unit. Aust N Z J Med (1990) 0.77
Spinal coccidioidomycosis in a baboon. J Am Vet Med Assoc (1984) 0.77
Pulmonary cryptococcosis in a rhesus monkey (Macaca mulatta). Mykosen (1984) 0.77
RFLP analysis of the HLA-, ChLA-, and RhLA-DQ alpha chain gene regions: conservation of restriction sites during evolution. Immunogenetics (1989) 0.76
Disseminated histoplasmosis in a SIV-infected rhesus monkey. J Med Primatol (1991) 0.76
Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40
An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol (2010) 3.75
Liver transplantation for the treatment of hepatocellular carcinoma. Oncology (Williston Park) (2011) 2.14
Biologics in organ transplantation. Transpl Int (2012) 2.06
Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation. Transpl Int (2006) 1.68
Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg (2005) 1.67
Developmental exposure to noninherited maternal antigens induces CD4+ T regulatory cells: relevance to mechanism of heart allograft tolerance. J Immunol (2007) 1.64
Evaluation of clinical outcomes of prophylactic versus preemptive cytomegalovirus strategy in liver transplant recipients. Transpl Int (2013) 1.50
Selenium-binding protein-1 in smooth muscle cells is downregulated in a rhesus monkey model of chronic allograft nephropathy. Am J Transplant (2005) 1.45
Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death. Transpl Int (2008) 1.44
Donation after cardiac death: the university of wisconsin experience with renal transplantation. Am J Transplant (2004) 1.26
Human CD4+CD25low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance. J Immunol (2007) 1.23
Risk factors and outcomes in post-liver transplantation bile duct stones and casts: A case-control study. Liver Transpl (2008) 1.23
Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction. Am J Transplant (2004) 1.19
Overcoming Chronic Rejection-Can it B? Transplantation (2009) 1.17
Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates. J Immunol (2004) 1.17
Donation after cardiac death: the University of Wisconsin experience. Ann Transplant (2004) 1.14
Campath-1H use in pediatric renal transplantation. Am J Transplant (2005) 1.13
T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients. Transplantation (2006) 1.12
Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. J Immunol (2008) 1.10
The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation. Transpl Int (2006) 1.08
CXCR3-mediated T-cell chemotaxis involves ZAP-70 and is regulated by signalling through the T-cell receptor. Immunology (2007) 1.04
Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention. Am J Transplant (2004) 1.03
Underutilization of pancreas donors. Transplantation (2003) 0.98
Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. J Rheumatol (2009) 0.98
Liver transplantation for HELLP syndrome. Liver Transpl (2005) 0.96
Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine. Transplantation (2009) 0.94
Simultaneous pancreas-kidney transplantation from donation after cardiac death: successful long-term outcomes. Ann Surg (2005) 0.93
Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model. Transplantation (2004) 0.93
Correlation between human leukocyte antigen antibody production and serum creatinine in patients receiving sirolimus monotherapy after Campath-1H induction. Transplantation (2004) 0.92
Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection. Hepatology (2012) 0.91
SU5416, a VEGF receptor inhibitor and ligand of the AHR, represents a new alternative for immunomodulation. PLoS One (2012) 0.89
Tolerogenic therapies in transplantation. Front Immunol (2012) 0.88
Racial and socioeconomic disparities in pediatric and young adult liver transplant outcomes. Liver Transpl (2013) 0.88
Interleukin-15 receptor blockade in non-human primate kidney transplantation. Transplantation (2010) 0.87
Surveillance of acute rejection in baboon renal transplantation by elevation of interferon-gamma inducible protein-10 and monokine induced by interferon-gamma in urine. Transplantation (2004) 0.87
The aryl hydrocarbon receptor: a novel target for immunomodulation in organ transplantation. Transplantation (2013) 0.86
Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times. J Surg Oncol (2013) 0.85
The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma. J Vasc Interv Radiol (2010) 0.85
Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. Transplantation (2003) 0.84
Determination of the functional status of alloreactive T cells by interferon-gamma kinetics. Transplantation (2006) 0.84
Superior long-term results of simultaneous pancreas-kidney transplantation from pediatric donors. Am J Transplant (2004) 0.83
Challenging choices: liver transplantation for hepatocellular carcinoma. Ann Surg (2004) 0.83
Infected bilomas in liver transplant recipients: clinical features, optimal management, and risk factors for mortality. Clin Infect Dis (2004) 0.82
The Association Between Hospital Finances and Complications After Complex Abdominal Surgery: Deficiencies in the Current Health Care Reimbursement System and Implications for the Future. Ann Surg (2015) 0.82
Piceatannol in combination with low doses of cyclosporine A prolongs kidney allograft survival in a stringent rat transplantation model. Transplantation (2002) 0.82
Urine proteomics in kidney transplantation. Transplant Rev (Orlando) (2013) 0.81
The Aryl Hydrocarbon Receptor Influences Transplant Outcomes in Response to Environmental Signals. Toxicol Environ Chem (2012) 0.81
Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells. Int Immunol (2003) 0.81
Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling. Transplantation (2003) 0.80
Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol (2008) 0.80
Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling. J Immunol (2010) 0.80
Induction immunosuppression in liver transplantation: a review. Transpl Int (2013) 0.80
Primary vascularization of the graft determines the immunodominance of murine minor H antigens during organ transplantation. J Immunol (2011) 0.79
Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation. Transplantation (2007) 0.79
Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection. Transplantation (2003) 0.79
Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation. Transplantation (2009) 0.79
The role of B cells in solid organ transplantation. Semin Immunol (2011) 0.79
Donor-specific HLA-antibody-mediated humoral rejection in a liver transplant recipient fully reversed with plasmapheresis and immunoglobulin. Clin Transpl (2006) 0.78
Amelioration of Clostridium difficile Infection in Mice by Dietary Supplementation With Indole-3-carbinol. Ann Surg (2016) 0.77
Long-term outcomes in simultaneous pancreas-kidney transplantation: lessons relearned. Clin Transpl (2003) 0.77
Systems biological analyses reveal the hepatitis C virus (HCV)-specific regulation of hematopoietic development. Hepatology (2015) 0.77
Impact of Leukocyte Function-Associated Antigen-1 Blockade on Endogenous Allospecific T Cells to Multiple Minor Histocompatibility Antigen Mismatched Cardiac Allograft. Transplantation (2015) 0.76
Gut Lymphocyte Phenotype Changes After Parenteral Nutrition and Neuropeptide Administration. Ann Surg (2015) 0.76
Reply to Vanhove et al. Transpl Int (2013) 0.75
Post-transplant lymphoproliferative disorder associated with immunosuppressive therapy for renal transplantation in rhesus macaques (Macaca mulatta). Exp Toxicol Pathol (2013) 0.75
Cross-talk between T and B Cells in the Germinal Center following Transplantation. Transplantation (2016) 0.75
The Volume-outcome Relationship in Deceased Donor Kidney Transplantation and Implications for Regionalization. Ann Surg (2017) 0.75
Liver transplantation 2007: where do we go from here? Curr Opin Organ Transplant (2007) 0.75
Cytokine kinetics profiling in pediatric renal transplant recipients. Pediatr Transplant (2010) 0.75
Incidental living donor nephrectomy: a unique expansion of the donor pool. Nephrol Dial Transplant (2005) 0.75
Starting well: induction immunosuppression after organ transplantation. Transpl Int (2013) 0.75
Immune status assay (ISA): a noninvasive procedure for studying allograft rejection. Transpl Immunol (2004) 0.75
Annual literature review for clinical transplants 2005. Clin Transpl (2005) 0.75
Liver transplantation for biliary atresia: 19-year, single-center experience. Exp Clin Transplant (2004) 0.75